NCT00436566
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +15 more
- Locations
-
- Mayo Clinic Cancer Research Consortium Rochester, Minnesota, United States
Clinical trial condition
Breast Neoplasms, Male
Explore clinical trials studying Breast Neoplasms, Male. Study availability and eligibility vary by location and protocol.
213 public trials
6 recruiting studies
Breast Neoplasms, Male trial results
NCT00468715
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
- Locations
-
- UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
- Lombardi Comprehensive Cancer Center at Georgetown University Medical Center Washington D.C., District of Columbia, United States
- Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Mayo Clinic Cancer Center Rochester, Minnesota, United States
Completed
TEEL Study- Phase 1 Tamoxifen and Ribociclib (LEE011) in Advanced ER+ (HER2 Negative) Breast Cancer
NCT02586675
- Conditions
- Breast Cancer, Breast Cancer - Female, Breast Cancer - Male, +11 more
- Locations
-
- H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
NCT00089323
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
- Locations
-
- Arkansas Cancer Research Center at University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
- Tunnell Cancer Center at Beebe Medical Center Lewes, Delaware, United States
- CCOP - Christiana Care Health Services Newark, Delaware, United States
- Morton Plant Hospital Clearwater, Florida, United States
Completed
Lisinopril or Coreg CR® in Reducing Side Effects in Women With Breast Cancer Receiving Trastuzumab
NCT01009918
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +15 more
- Locations
-
- Todd Cancer Institute at Long Beach Memorial Medical Center Long Beach, California, United States
- Olive View - UCLA Medical Center Foundation Sylmar, California, United States
- Aurora Presbyterian Hospital Aurora, Colorado, United States
- Boulder Community Hospital Boulder, Colorado, United States
Completed
Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer
NCT01037790
- Conditions
- Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, Adult Central Nervous System Germ Cell Tumor, +74 more
- Locations
-
- Abramson Cancer Center of The University of Pennsylvania Philadelphia, Pennsylvania, United States
NCT00470301
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +10 more
- Locations
-
- H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
- Mount Sinai Medical Center New York, United States
- Columbia University Medical Center New York, United States
- Weill Medical College of Cornell University New York, United States
NCT01570036
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
- Locations
-
- Samuel Oschin Comprehensive Cancer Institute - Cedars Sinai Medical Center Beverly Hills, California, United States
- Sarcoma Oncology Research Center, LLC Santa Monica, California, United States
- St. Joseph Heritage Healthcare Santa Rosa, California, United States
- Sibley Memorial Hospital Washington D.C., District of Columbia, United States
NCT00470574
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
- Locations
-
- Memorial Sloan Kettering Cancer Center New York, United States
NCT00562718
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
- Locations
-
- Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas Dallas, Texas, United States